These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
211 related articles for article (PubMed ID: 24729189)
1. Nature-inspired nanoformulations for contrast-enhanced in vivo MR imaging of macrophages. Sigalov AB Contrast Media Mol Imaging; 2014; 9(5):372-82. PubMed ID: 24729189 [TBL] [Abstract][Full Text] [Related]
2. Diagnostic Magnetic Resonance Imaging of Atherosclerosis in Apolipoprotein E Knockout Mouse Model Using Macrophage-Targeted Gadolinium-Containing Synthetic Lipopeptide Nanoparticles. Shen ZT; Zheng S; Gounis MJ; Sigalov AB PLoS One; 2015; 10(11):e0143453. PubMed ID: 26569115 [TBL] [Abstract][Full Text] [Related]
3. Incorporation of an apoE-derived lipopeptide in high-density lipoprotein MRI contrast agents for enhanced imaging of macrophages in atherosclerosis. Chen W; Vucic E; Leupold E; Mulder WJ; Cormode DP; Briley-Saebo KC; Barazza A; Fisher EA; Dathe M; Fayad ZA Contrast Media Mol Imaging; 2008; 3(6):233-42. PubMed ID: 19072768 [TBL] [Abstract][Full Text] [Related]
10. Anti-inflammatory drug evaluation in ApoE-/- mice by ultrasmall superparamagnetic iron oxide-enhanced magnetic resonance imaging. Sigovan M; Kaye E; Lancelot E; Corot C; Provost N; Majd Z; Breisse M; Canet-Soulas E Invest Radiol; 2012 Sep; 47(9):546-52. PubMed ID: 22864378 [TBL] [Abstract][Full Text] [Related]
11. Gadolinium-containing phosphatidylserine liposomes for molecular imaging of atherosclerosis. Maiseyeu A; Mihai G; Kampfrath T; Simonetti OP; Sen CK; Roy S; Rajagopalan S; Parthasarathy S J Lipid Res; 2009 Nov; 50(11):2157-63. PubMed ID: 19017616 [TBL] [Abstract][Full Text] [Related]
12. Biodegradable synthetic high-density lipoprotein nanoparticles for atherosclerosis. Marrache S; Dhar S Proc Natl Acad Sci U S A; 2013 Jun; 110(23):9445-50. PubMed ID: 23671083 [TBL] [Abstract][Full Text] [Related]
13. Gadolinium(III)-gold nanorods for MRI and photoacoustic imaging dual-modality detection of macrophages in atherosclerotic inflammation. Qin H; Zhou T; Yang S; Chen Q; Xing D Nanomedicine (Lond); 2013 Oct; 8(10):1611-24. PubMed ID: 23351094 [TBL] [Abstract][Full Text] [Related]
14. Molecular and cellular targets of the MRI contrast agent P947 for atherosclerosis imaging. Ouimet T; Lancelot E; Hyafil F; Rienzo M; Deux F; Lemaître M; Duquesnoy S; Garot J; Roques BP; Michel JB; Corot C; Ballet S Mol Pharm; 2012 Apr; 9(4):850-61. PubMed ID: 22352457 [TBL] [Abstract][Full Text] [Related]
16. Imaging monocytes with iron oxide nanoparticles targeted towards the monocyte integrin MAC-1 (CD11b/CD18) does not result in improved atherosclerotic plaque detection by in vivo MRI. von zur Muhlen C; Fink-Petri A; Salaklang J; Paul D; Neudorfer I; Berti V; Merkle A; Peter K; Bode C; von Elverfeldt D Contrast Media Mol Imaging; 2010; 5(5):268-75. PubMed ID: 20973112 [TBL] [Abstract][Full Text] [Related]